Hi,
On August 18, 2008 the FDA said it planned to strengthen warnings about life-threatening pancreas problems linked to the type 2 diabetes drug Byetta after getting two reports of deaths and four other hospitalizations in Byetta users. Those patients had hemorrhagic pancreatitis (inflammation of the pancreas with bleeding) or necrotizing pancreatitis (in which the inflamed pancreas destroys itself).
Patients who are taking Byetta should be observed carefully for signs and symptoms of pancreatitis, including persistent severe abdominal pain, sometimes radiating to the back, which may or may not be accompanied by vomiting. It is very important that you report all of your symptoms especially the episodes of diarrhea and hypoglycemia. Please do so as soon as your physician's office opens.
Maryann
Comment Reply
Hi,
October 13, 2011 - 2:42pmOn August 18, 2008 the FDA said it planned to strengthen warnings about life-threatening pancreas problems linked to the type 2 diabetes drug Byetta after getting two reports of deaths and four other hospitalizations in Byetta users. Those patients had hemorrhagic pancreatitis (inflammation of the pancreas with bleeding) or necrotizing pancreatitis (in which the inflamed pancreas destroys itself).
Patients who are taking Byetta should be observed carefully for signs and symptoms of pancreatitis, including persistent severe abdominal pain, sometimes radiating to the back, which may or may not be accompanied by vomiting. It is very important that you report all of your symptoms especially the episodes of diarrhea and hypoglycemia. Please do so as soon as your physician's office opens.
Maryann
This Comment
Reply